Reserpine: a relic from the past or a neglected drug of the present for achieving cost containment in treating hypertension?

J Gen Intern Med. 1991 Nov-Dec;6(6):561-72. doi: 10.1007/BF02598229.
No abstract available

Publication types

  • Review

MeSH terms

  • Antihypertensive Agents / therapeutic use
  • Benzothiadiazines
  • Cost Control
  • Diuretics
  • Drug Therapy, Combination
  • Humans
  • Hypertension / drug therapy*
  • Hypertension / economics
  • Reserpine / adverse effects
  • Reserpine / economics
  • Reserpine / therapeutic use*
  • Sodium Chloride Symporter Inhibitors / therapeutic use

Substances

  • Antihypertensive Agents
  • Benzothiadiazines
  • Diuretics
  • Sodium Chloride Symporter Inhibitors
  • Reserpine